Drug Profile
Niacin/simvastatin
Alternative Names: KS 01 019; Niaspan®/simvastatin; Nicotinic acid/simvastatin; SimcorLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Kos Pharmaceuticals
- Developer AbbVie
- Class Antihyperlipidaemics; Naphthalenes; Nicotinic acids; Peripheral vasodilators; Vitamins
- Mechanism of Action Cholesterol inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Hyperlipidaemia